LDL

🧬 AI profile — grown from 6ic coverage LDL (low‑density lipoprotein) is a particle that transports cholesterol in the bloodstream; elevated LDL levels are a primary risk factor for atherosclerotic cardiovascular disease. The FDA‑approved therapy works by dramatically lowering LDL concentrations, offering a non‑statin alternative for patients who cannot tolerate or achieve sufficient risk reduction with traditional statins. This development positions LDL reduction as the central mechanism behind the new treatment’s efficacy.